This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mark H. Cooley, MD; Phin Cohen, MD

Arch Intern Med. 1967;119(4):345-354.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In THEIR study of 36 patients, Oski et al found the plasma acid phenylphosphatase (PAPP) value to be a reliable parameter for separating destructive from nondestructive thrombocytopenias.¹ In six patients with acute idiopathic thrombocytopenic purpura (ITP) and in 13 of 15 cases of chronic ITP, elevation of PAPP was thought to reflect thrombocytolysis with release of the enzyme into the plasma. Conversely, in eight cases of hypoplastic thrombocytopenia the PAPP fell somewhat below the normal mean. With the exception of two patients with chronic ITP, the plasma enzyme values correlated well with platelet life-spans and bone marrow megakaryocyte activity. Thus, it was proposed that the PAPP value be added to the diagnostic tests used to classify the thrombocytopenias.

The present report concerns nine patients with ITP in whom an attempt was made to correlate PAPP levels with platelet counts, radioactive chromium (⁵¹Cr) platelet lifespans, and therapeutic response to . . . [Full Text PDF of this Article]

Author Affiliations
Boston

From the Richard C. Curtis Hematology Research Laboratory, Peter Bent Brigham Hospital, and the Department of Medicine, Harvard Medical School, Boston. Dr. Cooley was a Fellow in Hematology at the Harvard Medical School.

Footnotes
Received for publication Aug 19, 1966; accepted Dec 9.

Reprint requests to 275 Longwood Ave, Boston, Mass 02115 (Dr. Cooley).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?